Renata Plc (General Plant-2)
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Bangladesh
- Registered address
- Rajendrapur General Facility, Noyapara, Bhawal, Mirzapur, Rajendrapur, Gazipur, 1700, Bangladesh (BGD)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 3014008486 · DUNS 731721994
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2020-01-30
Drugs this plant is listed as making
2 distinct drugs across 10 products name this site in their FDA label.
- RisperidoneWestminster Pharmaceuticals, LLC
- Rosuvastatin CalciumWestminster Pharmaceuticals, LLC
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.